Terms: = Kidney tumors AND NRG1, ENSG00000157168, 3084, SMDF, NDF, HRGA, HRG1, HGL, GGF2, GGF, ARIA
11 results:
1. A Contemporary Clinicopathologic Analysis of Patients With Renal Cell Carcinoma and Vena Cava Involvement.
Al-Rusan OM; Patil D; Master VA; Osunkoya AO
Int J Surg Pathol; 2024 Apr; 32(2):279-285. PubMed ID: 37306114
[TBL] [Abstract] [Full Text] [Related]
2. Adding of neurotensin to non-small cell lung cancer cells increases tyrosine phosphorylation of HER3.
Moody TW; Ramos-Alvarez I; Jensen RT
Peptides; 2022 Oct; 156():170858. PubMed ID: 35932909
[TBL] [Abstract] [Full Text] [Related]
3. Urinary L-type fatty acid-binding protein is a predictor of cisplatin-induced acute kidney injury.
Yanishi M; Kinoshita H
BMC Nephrol; 2022 Mar; 23(1):125. PubMed ID: 35361160
[TBL] [Abstract] [Full Text] [Related]
4. Construction autophagy-related prognostic risk signature combined with clinicopathological validation analysis for survival prediction of kidney renal papillary cell carcinoma patients.
Fei H; Chen S; Xu C
BMC Cancer; 2021 Apr; 21(1):411. PubMed ID: 33858375
[TBL] [Abstract] [Full Text] [Related]
5. Bombesin, endothelin, neurotensin and pituitary adenylate cyclase activating polypeptide cause tyrosine phosphorylation of receptor tyrosine kinases.
Moody TW; Ramos-Alvarez I; Jensen RT
Peptides; 2021 Mar; 137():170480. PubMed ID: 33385499
[TBL] [Abstract] [Full Text] [Related]
6. The G Protein-Coupled Receptor PAC1 Regulates Transactivation of the Receptor Tyrosine Kinase HER3.
Moody TW; Lee L; Jensen RT
J Mol Neurosci; 2021 Aug; 71(8):1589-1597. PubMed ID: 32964398
[TBL] [Abstract] [Full Text] [Related]
7. Neuregulin-1 Administration Protocols Sufficient for Stimulating Cardiac Regeneration in Young Mice Do Not Induce Somatic, Organ, or Neoplastic Growth.
Ganapathy B; Nandhagopal N; Polizzotti BD; Bennett D; Asan A; Wu Y; Kühn B
PLoS One; 2016; 11(5):e0155456. PubMed ID: 27175488
[TBL] [Abstract] [Full Text] [Related]
8. Identifying patients with undetected renal tract cancer in primary care: an independent and external validation of QCancer® (Renal) prediction model.
Collins GS; Altman DG
Cancer Epidemiol; 2013 Apr; 37(2):115-20. PubMed ID: 23280341
[TBL] [Abstract] [Full Text] [Related]
9. Identifying patients with suspected renal tract cancer in primary care: derivation and validation of an algorithm.
Hippisley-Cox J; Coupland C
Br J Gen Pract; 2012 Apr; 62(597):e251-60. PubMed ID: 22520912
[TBL] [Abstract] [Full Text] [Related]
10. Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma.
Yamano Y; Uzawa K; Saito K; Nakashima D; Kasamatsu A; Koike H; Kouzu Y; Shinozuka K; Nakatani K; Negoro K; Fujita S; Tanzawa H
Int J Cancer; 2010 Jan; 126(2):437-49. PubMed ID: 19569180
[TBL] [Abstract] [Full Text] [Related]
11. Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.
Chen M; Ye Y; Yang H; Tamboli P; Matin S; Tannir NM; Wood CG; Gu J; Wu X
Int J Cancer; 2009 Nov; 125(10):2342-8. PubMed ID: 19521957
[TBL] [Abstract] [Full Text] [Related]
